Resultados de la búsqueda 921-930 of 3182 for pharmacogenetics

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Rochester, Minn. The purpose of this study is to estimate the circulating tumor DNA (ctDNA)detection rate and mutational load in breast cancer patients with ...

  2. Hematología - Ensayos clínicos

    This partially randomized clinical trial studies cholecalciferol in improving survival in patients with newly diagnosed cancer with vitamin D insufficiency.

  3. Ensayos clínicos - Neurología

    The purpose of the study is to learn more about inflammatory diseases of the central nervous system (CNS) by collecting patient information, blood sample (which ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to evaluate the safety of preoperative radiosurgery in the treatment of patients with biopsy-proven high grade glioma prior to conventional ...

  5. Ensayos clínicos - Hematología

    The purpose of this study is to determine the cellular and mechanistic basis of bone marrow hematopoietic dysfunction in untreated Monoclonal B Cell ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Many of the current imaging tests we have for prostate cancer are problematic in their ability to distinguish cancerous from non-cancerous prostate tissue.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This study aims to evaluate the outcomes and patient satisfaction with same day mastectomy with or without alloplastic reconstruction following COVID-19 and ...

  8. Ensayos clínicos - Neurología

    The purpose of this study is to develop a prospective status epilepticus registry among twelve tertiary care pediatric hospitals in the United States focused on ...

  9. Ensayos clínicos - Neurología

    The purpose of this study is to characterize the astrocyte response to various inflammatory drivers in the presence of innate immune cells collected from ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...